Jeongmin Hong, PhD
Postdoctoral Associate
Boston University Chobanian & Avedisian School of Medicine
Arthritis & Autoimmune Diseases Research Center



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Hong J, Pham TX, Lee J, Raslan AA, Nicolas K, Sharov A, Meridew JA, Urrutia RA, Lomberk G, Huang SK, Ligresti G. Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis. Am J Respir Cell Mol Biol. 2024 Dec 06.View Related Profiles. PMID: 39642371
     
  2. Raslan AA, Pham TX, Lee J, Kontodimas K, Tilston-Lunel A, Schmottlach J, Hong J, Dinc T, Bujor AM, Caporarello N, Thiriot A, von Andrian UH, Huang SK, Nicosia RF, Trojanowska M, Varelas X, Ligresti G. Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis. Nat Commun. 2024 Jun 27; 15(1):5449.View Related Profiles. PMID: 38937456; PMCID: PMC11211333; DOI: 10.1038/s41467-024-49545-x;
     
  3. Shiba-Ishii A, Isagawa T, Shiozawa T, Mato N, Nakagawa T, Takada Y, Hirai K, Hong J, Saitoh A, Takeda N, Niki T, Murakami Y, Matsubara D. Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC. Biochim Biophys Acta Mol Basis Dis. 2024 Aug; 1870(6):167249. PMID: 38768929
     
  4. Ligresti G, Raslan AA, Hong J, Caporarello N, Confalonieri M, Huang SK. Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis. Gene. 2023 Apr 05; 859:147142.View Related Profiles. PMID: 36603696; PMCID: PMC10068350; DOI: 10.1016/j.gene.2022.147142;
     
  5. Hong J, Shiba-Ishii A, Kim Y, Noguchi M, Sakamoto N. Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma. Cancer Sci. 2021 Dec; 112(12):5114-5126. PMID: 34628698; PMCID: PMC8645747; DOI: 10.1111/cas.15160;
     
  6. Hong J, Kim Y, Kano J, Dai T, Noguchi M. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Journal of Thoracic Oncology. 2021. View Publication
  7. Hong J, Kim Y, Shiba-Ishii A, Noguchi M. P1.03-18 OCIAD2 Impairs Mitochondria-Mediated Apoptosis Through Substantial Alteration of Crista Structure in Lung Adenocarcinoma. Journal of Thoracic Oncology. 2019. View Publication
  8. Husni RE, Shiba-Ishii A, Nakagawa T, Dai T, Kim Y, Hong J, Sakashita S, Sakamoto N, Sato Y, Noguchi M. DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma. Oncotarget. 2019 Feb 26; 10(17):1625-1636. PMID: 30899432; PMCID: PMC6422190; DOI: 10.18632/oncotarget.26676;
     
  9. Shiba-Ishii A, Hong J, Hirokawa T, Kim Y, Nakagawa T, Sakashita S, Sakamoto N, Kozuma Y, Sato Y, Noguchi M. Stratifin Inhibits SCFFBW7 Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis. Clin Cancer Res. 2019 May 01; 25(9):2809-2820. PMID: 30728155; DOI: 10.1158/1078-0432.CCR-18-3631;
     
  10. Shiba A, Hong J, Hirokawa T, Kim Y, Noguchi M. P1. 03-20 The Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination. Journal of Thoracic Oncology. 2018. View Publication
Showing 10 of 12 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 12 publications over 7 distinct years, with a maximum of 3 publications in 2019 and 2024

YearPublications
20081
20171
20181
20193
20212
20231
20243

Contact for Mentoring:

Hong's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (75) concept(s)
_
Co-Authors
See all (8) people
_
Similar People
See all (60) people
_
Same Department
Search Department